Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats

Brain Research

Volumn 975, Issue 1-2, 2003, Pages 229-236

  Cui, Shu Sen ^a,c   Yang, Christine P ^b   Bowen, Rudy C ^a   Bai, Ou ^a   Li, Xin Min ^a   Jiang, Wen ^a   Zhang, Xia ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c JILIN UNIVERSITY   (China)

Author keywords

Functional recovery; Peripheral nerve injury; Reinnervation; Valproate

Indexed keywords

VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HINDLIMB; MALE; MOTOR PERFORMANCE; MUSCLE CELL; MUSCLE REINNERVATION; MYELINATED NERVE; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NERVE FUNCTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SCIATIC NERVE; TOE;

EID: 0037728684     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02699-4     Document Type: Article

References (34)

1. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology. 46:1996;1244-1249.
2. Bain J.R., Mackinnon S.E., Hunter D.A. Functional evaluation of complete sciatic, peroneal and posterior tibial nerve lesions in the rat. Plast. Reconstr. Surg. 83:1989;129-138.
3. Bisby M.A. Enhancement of the conditioning lesion effect in rat sciatic motor axons after superimposition of conditioning and test lesions. Exp. Neurol. 90:1985;385-394.
4. Bondoux-Jahan M., Sebille A. Conditioning lesion effects on rat sciatic nerve regeneration are influenced by electrical stimulation delivered to denervated muscles. Brain Res. 490:1989;350-354.
5. Brooke M.H., Kaiser K.K. Muscle fibre types: how many and what kind? Arch. Neurol. 23:1970;369-379.
6. Brown C.J., Mackinnon S.E., Evans P.J., Bain J.R., Makino A.P., Hunter D.A., et al. Self-evaluation of walking-track measurement using a sciatic function index. Microsurgery. 10:1989;226-235.
7. Bruno V., Sortino M.A., Scapagnini U., Nicoletti F., Canonico P. Antidegenerative effects of Mg(2+) valproate in cultured cerebellar neurons. Funct. Neurol. 10:1995;121-130.
8. Chen G., Zeng W.Z., Jiang L., Yuan P.X., Zhao J., Manji H.K. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 72:1999;879-882.
9. Chen Z.Y., Chai Y.F., Cao L., Lu C.L., He C. Glial cell line-derived neurotrophic factor enhances axonal regeneration following sciatic nerve transection in adult rats. Brain Res. 902:2001;272-276.
10. Date I., Ohmoto T. Neuronal transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting. Exp. Neurol. 137:1996;333-344.
11. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54:1997;597-606.
12. Edwards D.L., Alpert R.M., Grafstein B. Recovery of vision in regeneration of goldfish optic axons: Enhancement of axonal outgrowth by a conditioning lesion. Exp. Neurol. 72:1981;672-686.
13. Frey H.H., Loscher W. Distribution of valproate across the interface between blood and cerebrospinal fluid. Neuropharmacology. 17:1978;637-642.
14. Gordon T., Fu S.Y. Long-term response to nerve injury. Adv. Neurol. 72:1997;185-199.
15. Jacob J.M., Croes S.A. Acceleration of axonal outgrowth in motor axons from mature and old F344 rats after a conditioning lesion. Exp. Neurol. 152:1998;231-237.
16. Loscher W., Frey H.H. Kinetics of penetration of common antiepileptics drugs into cerebrospinal fluid. Epilepsia. 25:1984;352-364.
17. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry. 48:2000;740-754.
18. 2+ deregulation, and cytoskeletal pathology. Neurobiol. Aging. 16:1995;187-198.
19. McElroy S.L., Keck P.E. Jr. Schatzberg A.F., Nemeroff C.B. Textbook of Psychopharmacology. 1995;351-375 American Psychiatric Press Inc, Washington DC.
20. McQqarrie I.G., Grafstein B. stei, Gershon M.D. Axonal regeneration in the rat sciatic nerve: Effect of a conditioning lesion and of dbcAMP. Brain Res. 132:1977;443-453.
21. McQqarrie I.G. Effect of a conditioning lesion on axonal sprout formation at nodes of Ranvier. J. Comp. Neurol. 231:1985;239-249.
22. Moneim M.S.A., Omer G.E. Clinical outcome following acute nerve repair. Omer G.E., Spinner M., Van Beek A.L. Management of Peripheral Nerve Problems. 2nd Edition: 1998;414-419 WB Saunders Company Press, Philadelphia.
23. Mora A., Gonzalez-Polo R.A., Fuentes J.M., Soler G., Centeno F. Different mechanisms of protection against apoptosis by valproate and Li+. Eur. J. Biochem. 266:1999;886-891.
24. Pardridge W.M., Kang Y.S., Buciak J.L. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11:1994;738-746.
25. Poduslo J.F., Curran G.L. Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers. Mol. Brain Res. 23:1993;157-162.
26. Poduslo J.F., Curran G.L. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3. BDNF. Brain Res. 36:1995;280-286.
27. Smith M.A., Makino S., Altemus M., Michelson D., Hong S.K., Kvetnansky R., et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc. Natl. Acad. Sci. USA. 92:1995;8788-8792.
28. Sunderland S. Nerve and Nerve Injuries: A Critical Appraisal - Changes in Denervated Muscle. 1991;241-246 Livingstone Press, Edinburgh.
29. Szupera Z., Mezei Z., Kis B., Gecse A., Vecsei L., Telegdy G. The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets. Eur. J. Pharmacol. 387:2000;205-210.
30. Tuszynski M.H., Gabriel K., Gage F.H., Suhr S., Meyer S., Rosetti A. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp. Neurol. 137:1996;157-173.
31. ® System. 1999;SAS Institute Inc, Cary (USA).
32. Yeh L.S., Gregory C.R., Theriault B.R., Hou S.M., Lecouter R.A. A functional model for whole limb transplantation in the rat. Plast. Reconstr. Surg. 105:2000;1704-1711.
33. Yin Q., Kemp G.K., Yu L.G., Wagstaff S.C., Frostick S.P. Neurotrophin-4 delivered by fibrin glue promotes peripheral nerve regeneration. Muscle Nerve. 24:2001;345-351.
34. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276:2001;31674-31683.